Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma

Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma

© 2020 The Authors Hu et al. provide an integrated proteomic and glycoproteomic characterization of high-grade serous ovarian carcinomas and relevant non-tumor tissues, which reveals tumor-specific glycosylation, uncovers different glycosylation associated with three tumor clusters, and identifies g...

Full description

Bibliographic Details
Format:	Article
Language:	English
Published:	Elsevier BV 2021
Online Access:	https://hdl.handle.net/1721.1/133605

Similar Items

Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma
Published: (2022)

Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
by: Se Ik Kim, et al.
Published: (2020-03-01)

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Published: (2018)

Molecular Management of High-Grade Serous Ovarian Carcinoma
by: Paula Punzón-Jiménez, et al.
Published: (2022-11-01)

Proteome profiling of low grade serous ovarian cancer
by: Haniyeh Bashi zadeh fakhar, et al.
Published: (2019-07-01)

Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review.
by: Chen, F, et al.
Published: (2017)

Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas
by: Hidenori Machino, et al.
Published: (2023-10-01)

Frequency of serous tubal intraepithelial carcinoma (STIC) in patients with high grade serous ovarian cancer
by: Jung Mi Byun, et al.
Published: (2023-01-01)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
by: Puja Dey, et al.
Published: (2022-03-01)

Integrated glycoproteomic characterization of clear cell renal cell carcinoma
by: T. Mamie Lih, et al.
Published: (2023-05-01)

High-grade serous ovarian carcinoma organoids as models of chromosomal instability
by: Maria Vias, et al.
Published: (2023-05-01)

Fallopian tube origin of supposed ovarian high-grade serous carcinomas
by: Patricia Martini Diniz, et al.
Published: (2011-01-01)

Convergence of Plasma Metabolomics and Proteomics Analysis to Discover Signatures of High-Grade Serous Ovarian Cancer
by: Hee-Sung Ahn, et al.
Published: (2020-11-01)

Proteomic Studies on the Management of High-Grade Serous Ovarian Cancer Patients: A Mini-Review
by: Melissa Bradbury, et al.
Published: (2021-04-01)

Clinical Implications of DNA Repair Defects in High-Grade Serous Ovarian Carcinomas
by: Michela Camilla Milanesio, et al.
Published: (2020-05-01)

The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
by: Philip Smith, et al.
Published: (2023-07-01)

Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma
by: Rosie T. Jiang, et al.
Published: (2017-08-01)

Proteomic analysis of exosomes secreted during the epithelial-mesenchymal transition and potential biomarkers of mesenchymal high-grade serous ovarian carcinoma
by: Germano Aguiar Ferreira, et al.
Published: (2023-11-01)

A therapeutic approach to low-grade serous ovarian carcinoma
by: Branka Petrić-Miše, et al.
Published: (2020-01-01)

AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization
by: Eros Azzalini, et al.
Published: (2022-01-01)

Integrated proteomic, phosphoproteomic, and N-glycoproteomic analyses of the longissimus thoracis of yaks
by: Xinping Chang, et al.
Published: (2022-01-01)

Integrated Proteomic and N-Glycoproteomic Profiling of Placental Tissues of Patients with Preeclampsia
by: Wang H, et al.
Published: (2023-01-01)

Molecular and phenotypic characteristics influencing the degree of cytoreduction in high‐grade serous ovarian carcinomas
by: Cecilie Fredvik Torkildsen, et al.
Published: (2023-07-01)

Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma
by: Zibi Marchocki, et al.
Published: (2022-05-01)

Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma
by: Ruifen Dong, et al.
Published: (2016-09-01)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
by: Nkechiyere G. Nwani, et al.
Published: (2018-08-01)

Methylomic Signatures of High Grade Serous Ovarian Cancer
by: Horacio Cardenas, et al.
Published: (2021-11-01)

Cell Origins of High-Grade Serous Ovarian Cancer
by: Jaeyeon Kim, et al.
Published: (2018-11-01)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
by: M. Sharon Stack, et al.
Published: (2018-12-01)

Resistance prediction in high‐grade serous ovarian carcinoma with neoadjuvant chemotherapy using data‐independent acquisition proteomics and an ovary‐specific spectral library
by: Liujia Qian, et al.
Published: (2023-08-01)

Characterization of candidate factors associated with the metastasis and progression of high-grade serous ovarian cancer
by: Huiping Liu, et al.
Published: (2023-12-01)

Esophageal Infiltration by High-Grade Serous Ovarian Carcinoma: A Very Rare Case Report
by: Anna Carbó-Bagué, et al.
Published: (2023-11-01)

High-grade serous carcinoma arising in postmenopausal ovarian endometrioma: A rarely encountered case
by: Burak Giray, et al.
Published: (2022-09-01)

The Claudin-Low Subtype of High-Grade Serous Ovarian Carcinoma Exhibits Stem Cell Features
by: Chiara Romani, et al.
Published: (2021-02-01)

Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
by: Philip Smith, et al.
Published: (2023-09-01)

Development of Machine Learning Models to Predict Platinum Sensitivity of High-Grade Serous Ovarian Carcinoma
by: Suhyun Hwangbo, et al.
Published: (2021-04-01)

T-Cell Receptor Repertoire Characteristics Associated with Prognostic Significance in High-Grade Serous Ovarian Carcinoma
by: Ju-Won Kim, et al.
Published: (2023-03-01)

The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian Carcinoma
by: Mikhail S. Chesnokov, et al.
Published: (2021-03-01)

Molecular Analysis of Short- versus Long-Term Survivors of High-Grade Serous Ovarian Carcinoma
by: Elaine Stur, et al.
Published: (2022-08-01)

Changes in Nucleolin Expression during Malignant Transformation Leading to Ovarian High-Grade Serous Carcinoma
by: Elizabeth A. Paris, et al.
Published: (2023-01-01)